These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 15939311

  • 1. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E, Van De Velde V, Marissens S, Engelstätter R, Vincken W, Pauwels R.
    Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
    [Abstract] [Full Text] [Related]

  • 2. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

  • 3. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma.
    Derom E, Louis R, Tiesler C, Engelstätter R, Kaufman JM, Joos GF.
    Eur Respir J; 2009 Jun; 33(6):1277-86. PubMed ID: 19164356
    [Abstract] [Full Text] [Related]

  • 4. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S, Engelstätter R, Weber HJ, Hirsch S, Barkai L, Emeryk A, Weber H, Vermeulen J.
    Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
    [Abstract] [Full Text] [Related]

  • 6. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
    Xu J, Nave R, Lahu G, Derom E, Derendorf H.
    J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
    [Abstract] [Full Text] [Related]

  • 7. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma.
    Dahl R, Engelstätter R, Trebas-Pietraś E, Kuna P.
    Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601
    [Abstract] [Full Text] [Related]

  • 8. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED, Linnhof AE, Homik L, Freudensprung U, Smau L, Engelstätter R.
    Pulm Pharmacol Ther; 2008 Aug; 21(2):264-75. PubMed ID: 17604664
    [Abstract] [Full Text] [Related]

  • 9. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma.
    Buhl R, Vinkler I, Magyar P, Györi Z, Rybacki C, Middle MV, Escher A, Engelstätter R.
    Pulm Pharmacol Ther; 2006 Aug; 19(6):404-12. PubMed ID: 16310388
    [Abstract] [Full Text] [Related]

  • 10. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
    Lipworth BJ, Kaliner MA, LaForce CF, Baker JW, Kaiser HB, Amin D, Kundu S, Williams JE, Engelstaetter R, Banerji DD.
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
    [Abstract] [Full Text] [Related]

  • 11. Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients.
    Kim K, Quesada J, Szmaydy-Rikken N, Darken P, Shah T.
    J Asthma; 2007 Sep; 44(7):515-20. PubMed ID: 17885853
    [Abstract] [Full Text] [Related]

  • 12. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.
    Boulet LP, Bateman ED, Voves R, Müller T, Wolf S, Engelstätter R.
    Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650
    [Abstract] [Full Text] [Related]

  • 13. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
    Taylor DA, Jensen MW, Kanabar V, Engelstätter R, Steinijans VW, Barnes PJ, O'Connor BJ.
    Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
    [Abstract] [Full Text] [Related]

  • 14. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
    Clark DJ, Grove A, Cargill RI, Lipworth BJ.
    Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
    Nielsen LP, Dahl R.
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
    [Abstract] [Full Text] [Related]

  • 16. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
    Szefler S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D.
    Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
    [Abstract] [Full Text] [Related]

  • 17. Airway responsiveness to adenosine after a single dose of fluticasone propionate discriminates asthma from COPD.
    Spicuzza L, Scuderi V, Morjaria JB, Prosperini G, Arcidiacono G, Caruso M, Folisi C, Di Maria GU, Polosa R.
    Pulm Pharmacol Ther; 2014 Feb; 27(1):70-5. PubMed ID: 23688422
    [Abstract] [Full Text] [Related]

  • 18. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR, Patel P, D'Urzo AD, Alexander M, Mehra S, Oedekoven C, Engelstätter R, Boulet LP.
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [Abstract] [Full Text] [Related]

  • 19. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.